HOME › DRUGS › INSULIN GLARGINE RECOMBINANT
ACTIVE SUBSTANCE / INN

INSULIN GLARGINE RECOMBINANT

Brand name(s): LANTUS SOLOSTAR, TOUJEO SOLOSTAR, TOUJEO MAX SOLOSTAR, LANTUS
FDA LISTED
PRESCRIPTION
BLA021081
BLA206538
ACTIVE SUBSTANCE
Insulin Glargine Recombinant
REGULATORS
FDA
SPONSORS / MAH
SANOFI AVENTIS US, SANOFI US SERVICES
TOTAL APPLICATIONS
4
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TOUJEO SOLOSTARBLA206538SANOFI US SERVICESPrescription
TOUJEO MAX SOLOSTARBLA206538SANOFI US SERVICESPrescription
LANTUS SOLOSTARBLA021081SANOFI AVENTIS USPrescription
LANTUSBLA021081SANOFI AVENTIS USPrescription

FULL INTELLIGENCE ON INSULIN GLARGINE RECOMBINANT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →